LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020)
LifeMD (LFMD) reported Asset Writedowns and Impairment of $74530.0 for Q4 2020, up 1728.72% quarter-over-quarter from -$4576.0 in Q3 2017.
LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020) Analysis & Trends
LifeMD has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $74530.0 in Q4 2020.
- For the quarter ending Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to $74530.0; the trailing twelve-month figure through Dec 2021 stood at $74530.0 (up 17.48% YoY), and the FY2024 full-year result was $675669.0, up 25.66% from the prior year.
- Asset Writedowns and Impairment for Q4 2020 stood at $74530.0, up from -$4576.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $114694.0 in Q4 2016, with the low at -$38027.0 in Q1 2017.
- Historically, Asset Writedowns and Impairment has averaged $28021.0 across 3 years, with a median of -$4576.0 in 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | LifeMD | 226.03 Mn | 226.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 74,530.00 |
| Dec 31, 2020 | 74,530.00 |
| Sep 30, 2017 | -4,576.00 |
| Sep 30, 2017 | -4,576.00 |
| Jun 30, 2017 | -6,516.00 |
| Jun 30, 2017 | -6,516.00 |
| Mar 31, 2017 | -38,027.00 |
| Mar 31, 2017 | -38,027.00 |
| Dec 31, 2016 | 114,694.00 |
| Dec 31, 2016 | 114,694.00 |